
### [NCIT:C128801](http://purl.obolibrary.org/obo/NCIT_C128801)
**Label:** Cutaneous Malignant Melanoma 2

**Subclasses:** 

**Class expressions from DL-Learner:**

- [NCIT:C18022](http://purl.obolibrary.org/obo/NCIT_C18022) (CDKN2A Gene) 53.57%
- Thing 53.00%
- [NCIT:C18593](http://purl.obolibrary.org/obo/NCIT_C18593) (Cyclin-Dependent Kinase Inhibitor Gene) 38.93%
- [NCIT:C18593](http://purl.obolibrary.org/obo/NCIT_C18593) (Cyclin-Dependent Kinase Inhibitor Gene) and (not ([NCIT:C40163](http://purl.obolibrary.org/obo/NCIT_C40163) (Uterine Corpus Cellular Leiomyoma))) 38.93%
- [NCIT:C18593](http://purl.obolibrary.org/obo/NCIT_C18593) (Cyclin-Dependent Kinase Inhibitor Gene) and (not ([NCIT:C40162](http://purl.obolibrary.org/obo/NCIT_C40162) (Uterine Corpus Leiomyoma, Mitotically Active Variant))) 38.93%
- [NCIT:C18593](http://purl.obolibrary.org/obo/NCIT_C18593) (Cyclin-Dependent Kinase Inhibitor Gene) and (not ([NCIT:C40161](http://purl.obolibrary.org/obo/NCIT_C40161) (JAZF1-SUZ12 Fusion Protein Expression))) 38.93%
- [NCIT:C18593](http://purl.obolibrary.org/obo/NCIT_C18593) (Cyclin-Dependent Kinase Inhibitor Gene) and (not ([NCIT:C40160](http://purl.obolibrary.org/obo/NCIT_C40160) (t(7;17)(p15;q21)))) 38.93%
- [NCIT:C18593](http://purl.obolibrary.org/obo/NCIT_C18593) (Cyclin-Dependent Kinase Inhibitor Gene) and (not ([NCIT:C40156](http://purl.obolibrary.org/obo/NCIT_C40156) (Endometrial Undifferentiated Carcinoma))) 38.93%
- [NCIT:C18593](http://purl.obolibrary.org/obo/NCIT_C18593) (Cyclin-Dependent Kinase Inhibitor Gene) and (not ([NCIT:C40155](http://purl.obolibrary.org/obo/NCIT_C40155) (Endometrial Small Cell Carcinoma))) 38.93%
- [NCIT:C18593](http://purl.obolibrary.org/obo/NCIT_C18593) (Cyclin-Dependent Kinase Inhibitor Gene) and (not ([NCIT:C40154](http://purl.obolibrary.org/obo/NCIT_C40154) (Endometrial Transitional Cell Carcinoma))) 38.93%
- [NCIT:C18593](http://purl.obolibrary.org/obo/NCIT_C18593) (Cyclin-Dependent Kinase Inhibitor Gene) and (not ([NCIT:C40153](http://purl.obolibrary.org/obo/NCIT_C40153) (Endometrial Mixed Adenocarcinoma))) 38.93%
- [NCIT:C18593](http://purl.obolibrary.org/obo/NCIT_C18593) (Cyclin-Dependent Kinase Inhibitor Gene) and (not ([NCIT:C40152](http://purl.obolibrary.org/obo/NCIT_C40152) (Serous Endometrial Intraepithelial Carcinoma))) 38.93%
- [NCIT:C18593](http://purl.obolibrary.org/obo/NCIT_C18593) (Cyclin-Dependent Kinase Inhibitor Gene) and (not ([NCIT:C40151](http://purl.obolibrary.org/obo/NCIT_C40151) (Grade 3 Endometrial Mucinous Adenocarcinoma))) 38.93%
- [NCIT:C18593](http://purl.obolibrary.org/obo/NCIT_C18593) (Cyclin-Dependent Kinase Inhibitor Gene) and (not ([NCIT:C40150](http://purl.obolibrary.org/obo/NCIT_C40150) (Grade 2 Endometrial Mucinous Adenocarcinoma))) 38.93%
- [NCIT:C18593](http://purl.obolibrary.org/obo/NCIT_C18593) (Cyclin-Dependent Kinase Inhibitor Gene) and (not ([NCIT:C40149](http://purl.obolibrary.org/obo/NCIT_C40149) (Grade 1 Endometrial Mucinous Adenocarcinoma))) 38.93%


